Division of Infectious Diseases, Tufts University, Cummings School of Veterinary Medicine, 200 Westboro Road, North Grafton, MA 01536, USA.
Vaccine. 2010 Sep 24;28(41):6658-65. doi: 10.1016/j.vaccine.2010.08.016. Epub 2010 Aug 13.
Bacillus subtilis strains expressing tetanus toxin fragment C (TTFC) were tested as vaccine candidates against tetanus in adult mice. Mice received three intranasal (IN) exposures to 10(9) spores or 10(8) vegetative cells of B. subtilis expressing recombinant TTFC. Immunized mice generated protective systemic and mucosal antibodies and survived challenge with 2× LD(100) of tetanus toxin. Isotype analysis of serum antibody indicated a balanced Th1/Th2 response. Lyophilized vaccines stored at 45° C for ≥ 12 months, remained effective. Immunized conventional and SCID mice remained well, and no histological changes in brain or respiratory tract were detected. Lyophilized/reconstituted B. subtilis tetanus vaccines administered IN to mice appear safe, heat-stable, and protective against lethal tetanus challenge.
枯草芽孢杆菌表达破伤风毒素片段 C(TTFC)菌株被测试作为成人口服破伤风疫苗候选物。小鼠接受了三次鼻腔内(IN)暴露于表达重组 TTFC 的枯草芽孢杆菌 10(9)个孢子或 10(8)个营养细胞。免疫接种的小鼠产生了保护性的系统和粘膜抗体,并能抵抗 2×LD(100)破伤风毒素的挑战。血清抗体的同种型分析表明存在平衡的 Th1/Th2 反应。在 45°C 下储存≥12 个月的冻干疫苗仍然有效。免疫接种的常规和 SCID 小鼠状况良好,未检测到大脑或呼吸道的组织学变化。冻干/复水枯草芽孢杆菌破伤风疫苗经 IN 途径给药给小鼠,安全性好,耐热,能有效预防致命性破伤风挑战。